Skip to main content

Table 2 Meta-analyses of the efficacy of different types of treatment at post-treatment regarding primary and secondary outcomes

From: The relative efficacy of bona fide psychotherapies for post-traumatic stress disorder: a meta-analytical evaluation of randomized controlled trials

Treatments

k

Hedges’ g

p

Q

p

I 2

Cognitive behavior therapy (all)

15

−0.02 [−0.17, 0.14]

.843

21.89

.081

38 % (0–64 %)

  

−0.03 [−0.18, 0.13]

.735

26.25

.024

50 % (5–70 %)

Trauma focused cognitive behavior therapy with exposure (subgroup)

10

0.03 [−0.15, 0.22]

.724

14.86

.095

42 % (42–88 %)

Exposure

10

0.03 [−0.17, 0.23]

.802

20.05

.018

59 % (59–90 %)

7

0.17 [−0.04, 0.37]

.112

4.14

.658

0 % (0–58 %)

  

−0.06 [−0.24, 0.13]

.556

6.22

.399

0 % (0–72 %)

Prolonged exposure

7

0.01 [−0.26, 0.28]

.927

14.98

.020

55 % (13–82 %)

  

−0.02 [−0.39, 0.35]

.914

26.70

.0002

82 % (54–89 %)

Exposure + prolonged exposure

14

0.10 [−0.07, 0.26]

.240

19.33

.113

33 % (0–63 %)

  

−0.02 [−0.20, 0.17]

.853

33.18

.002

57 % (31–78 %)

EMDR

6

0.01 [−0.45, 0.48]

.959

17.02

.005

70 % (35–87 %)

  

0.17 [−0.32, 0.66]

.505

17.97

.003

73 % (39–87 %)

Present-centered therapies

6

−0.17 [−0.32, 0.00]

.038

4.38

.496

15 % (0–72 %)

  

−0.04 [−0.15, 0.07]

.468

5.39

.370

0 % (0–77 %)

TF vs. NTF

9

0.14 [0.01, 0.27]

.030

7.31

.504

8 % (8–80 %)

  

0.06 [−0.04, 0.15]

.269

9.16

.329

0 % (0–96 %)

  1. Note. k = number of comparisons; Q = statistic of effect size heterogeneity. Values of Hedges’ g and I 2 are presented alongside their 95 % confidence intervals. Hedges’ g > 0 signifies a higher efficacy for the type of treatment of interest compared to all other available treatments, Hedges’ g < 0 signifies a lower efficacy. Per type of treatment, values in the first line pertain to primary outcomes (i.e., PTSD symptom severity), values in the second line to secondary outcomes (i.e., symptom severity of comorbid disorders, trauma-related symptoms, general symptom distress, social functioning, and quality of life)